# Commercial Implementation Playbook

**Target Markets and Go-to-Market Strategy for Genesys-E-DNA-E**

---

## Market Thesis

**Problem:** Organizations deploying AI systems lack a defensible framework for proving they thought about safety before deployment. This creates:
- Regulatory uncertainty (FDA, EU AI Act, SEC)
- Insurance underwriting confusion
- Liability exposure
- Board accountability gaps

**Solution:** Genesys-E-DNA-E provides the framework + proof generation + audit trail.

**Why now:** Regulators are demanding this, companies are desperate for this, investors are pricing in this risk.

---

## Target Markets (In Priority Order)

### 1. Healthcare Systems (Highest Urgency)

**Pain Point:** FDA requires Model Risk Management for AI/ML medical devices. Most hospitals don't have frameworks.

**Buyer:** Chief Medical Information Officer, Risk Management, Compliance

**Pitch:**
> "Use Genesys-E-DNA-E to generate FDA-compliant evaluation reports automatically. Every deployment decision is documented with independent verification, auditable back to clinical data."

**Deal Structure:**
- Evaluation API: $500/evaluation
- Annual license for hospital: $50k-$200k depending on volume
- TAM: ~6,000 US hospitals, ~2,000 with active AI deployment programs

**Go-to-Market:**
1. Partner with one major health system for pilot (unpaid to get case study)
2. Document in peer-reviewed medical informatics journal
3. Approach hospital networks (Epic, Cerner, Mayo Clinic)

**Timeline:** 6-month sales cycle typical

---

### 2. Insurance Companies (Highest Margin)

**Pain Point:** Insurance underwriting teams don't know how to evaluate AI risk. They're pricing blind.

**Buyer:** Chief Risk Officer, Model Risk Management team

**Pitch:**
> "Use Genesys-E-DNA-E to tier AI deployment insurance premiums. High-Index deployments get preferred rates. Companies optimize toward safer deployment."

**Deal Structure:**
- Licensing fee: $200k-$500k per insurer annually
- Per-company evaluation: $10k-$50k
- Revenue share: Genesys takes 20% of premium savings

**TAM:** Top 20 commercial insurers × average $5M annual AI risk premium = $100M market

---

### 3. Autonomous Vehicle Operators (Medium-term)

**Pain Point:** Regulators will demand proof of safety thinking before licensing.

**Buyer:** Safety Officer, Regulatory Affairs

**Pitch:**
> "Genesys-E-DNA-E generates the regulatory submission package. Shows you systematically thought about failure modes before deployment."

**Implementation:** Rate-limited capability escalation (start with geofenced 5mph, unlock higher speeds at higher Index)

---

### 4. Financial Institutions (Steady Revenue)

**Pain Point:** Basel III compliance, model risk management, SEC scrutiny of algorithmic trading.

**Buyer:** Chief Risk Officer, Compliance, Model Risk Management

**Implementation:** Audit trail for algorithm deployment, governance documentation

---

## Product Positioning

### NOT This:

❌ "Responsible AI governance framework"  
❌ "Ethics compliance tool"  
❌ "Safety evaluation SDK"

### THIS:

✅ **"Deploy-or-Don't-Deploy Risk Engine"**  
✅ "Generates FDA/EU/SEC-compliant audit trails"  
✅ "Ties insurance premiums to safety confidence"  
✅ "Reduces liability exposure through documentation"

**Tag:** "The decision support tool for AI deployment governance"

---

## Go-to-Market Timeline

### Month 1-2: Positioning

- [ ] Create case studies (work with 2 beta customers, even unpaid)
- [ ] Write regulatory white paper (FDA/EU AI Act mapping)
- [ ] Film technical demo (5 min walkthrough)
- [ ] Publish medical informatics paper

### Month 3-4: Sales Enablement

- [ ] Build hospital industry sales deck
- [ ] Insurance industry sales deck
- [ ] Create pricing calculator
- [ ] Develop API documentation for integrations

### Month 5-6: Launch

- [ ] Apply to FDA's Software Precertification program
- [ ] Present at HIMSS (healthcare IT conference)
- [ ] Approach insurance industry via Marsh McLennan
- [ ] Launch website + pricing page

### Month 7-12: First Customers

- [ ] Close 2-3 hospital pilots
- [ ] Close 1-2 insurance pilots
- [ ] $500k-$1M ARR goal

---

## Pricing Strategy

### SaaS + Consumption

**Base:** Annual platform license  
**Plus:** Per-evaluation fees based on deployment scope

| Model | Use Case | Price |
|-------|----------|-------|
| Startup | SMB healthcare | $10k/year |
| Mid-Market | Hospital system (5-10 deployments/year) | $50k/year |
| Enterprise | Insurance company | $250k/year |
| Per-Evaluation | Ad-hoc | $500-$5k |

**Volume discount:** 20% for >50 evaluations/year

---

## Sales Strategy

### For Healthcare:

1. **Conference:** HIMSS, AMIA, Health IT Leadership Summit
2. **Channels:** Healthcare IT consultants (Deloitte, McKinsey), Hospital CIOs
3. **Proof:** Case study from major hospital system (Mayo, Cleveland Clinic, Partners)

### For Insurance:

1. **Conference:** Risk Management Association, Insurance Information Institute
2. **Channels:** Insurance brokers (Marsh McLennan, Aon, Willis Towers Watson)
3. **Proof:** White paper on AI risk underwriting

### For AV/Industrial:

1. **Conference:** NHTSA, European safety conferences
2. **Direct:** Deploy operators (Waymo, Cruise, Uber ATG)
3. **Regulation:** EU AI Act implementation timelines

---

## Competitive Landscape

### Existing "AI Governance" Tools

- **Notchmeyer, MLflow, Weights & Biases:** Model tracking (not evaluation gating)
- **Responsible AI Initiative, Google AI**, Meta transparency:** Principles, not executable frameworks
- **ISO/IEC standards:** Emerging but not operationalized yet

**Our Advantage:**
- ✅ Mathematically rigorous (not just principles)
- ✅ Institutionally aligned (roles, audit trails)
- ✅ Enforcement mechanism (capability control interface)
- ✅ Domain-specific (not one-size-fits-all)
- ✅ Operationalized (code ready, tests written)

### No direct competitors yet (first-mover advantage)

---

## Risk Factors & Mitigations

| Risk | Mitigation |
|------|-----------|
| Regulators don't adopt our framework | Build to existing standards (FDA MRM, EU AI Act); position as translator |
| Customers want custom rules | Plugin architecture built in; charge for custom validators |
| Technical sophistication barrier | Provide hosted API; white-label dashboards |
| Enterprise IT resistance | Sales team + deep integrations (Epic, Salesforce) |
| Liability concerns | Clear disclaimers; E&O insurance; tool is advisory, humans decide |

---

## First Customer Playbook

### Customer Profile:

**Organization:** Mid-size hospital system (500-1000 beds) with 3-5 active AI deployments

**Budget:** $50k-$100k annual

**Decision Timeline:** 3-4 months

**Stakeholders:** CMIO, Chief Compliance Officer, IT Director

### Acquisition Path:

1. **Inbound:** Marketing/events drives lead to demo
2. **Discovery:** 30-min call: "How do you currently govern AI deployments?"
3. **Proposal:** 7-day pilot (free or $5k)
4. **Pilot:** Deploy one evaluation workflow end-to-end
5. **Close:** Expand to full platform

### Success Metrics for Pilot:

- ✅ Successfully evaluate 1 live deployment
- ✅ Generate FDA-format audit trail
- ✅ Run through full role-based workflow (proposer/estimator/approver)
- ✅ Customer says "this is what we've been asking compliance for"

---

## Regulatory Roadmap

### Phase 1: Voluntary Adoption (Now - 12 months)

- Deploy to healthcare systems, insurers, autonomous operators
- Build case studies and published evidence
- Goal: 10-20 customers, $500k-$1M ARR

### Phase 2: Standard Alignment (12-24 months)

- Work with FDA, EU regulators to align on framework
- Contribute to emerging AI governance standards
- Goal: Framework adopted by 30%+ of evaluations

### Phase 3: Regulatory Requirement (24+ months)

- Regulators require evaluation framework for AI deployment approval
- Our framework becomes de facto standard
- Goal: B2B SaaS business at $50M+ ARR

---

## Success Metrics

### Quarterly Goals:

**Q1 (Current):**
- [ ] 2 pilot customers
- [ ] $50k ARR
- [ ] Published case study
- [ ] 500 website visitors/month

**Q2:**
- [ ] 5 customers
- [ ] $150k ARR
- [ ] Speaking slot at major conference
- [ ] 2000 website visitors/month

**Q3:**
- [ ] 10 customers
- [ ] $400k ARR
- [ ] Peer-reviewed publication
- [ ] First enterprise deal

**Q4:**
- [ ] 15+ customers
- [ ] $750k-$1M ARR
- [ ] Series A funding conversation

---

## Funding Ask

**$2-3M Series A for:**
- Sales team (6 enterprise AEs, 2 SMB AEs)
- Customer success (onboarding, implementation, support)
- Product development (advanced analytics, custom validators)
- Marketing (conferences, content, events)
- Operations (legal, finance, compliance)

**Use of funds breakdown:**
- Sales & Marketing: 40%
- Product & Engineering: 25%
- Customer Success: 20%
- Operations: 15%

**Path to profitability:** Month 18-20

---

## Why This Matters

Genesys-E-DNA-E is not just an interesting technical framework. It's **infrastructure for a regulated industry**.

Once regulators start requiring deployment governance documentation (which they will), everyone will need something like this. The companies that have it first, that are deeply integrated with customers' workflows, that have regulatory endorsement—those win.

This is a "pick-and-shovel" play. While others are building fancy AI models, we're building the framework they must deploy through.

**Bottom line:** Early-stage bet that becomes $100M+ SaaS in 5 years as AI regulation tightens.

---

**Next Steps:**
1. Finalize pitch deck
2. Identify first 3 customer targets
3. Set up customer meetings
4. Prepare pilot engagement
